| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹78.40 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹78.40 Cr |
| Fresh Issue | ₹74.48 Cr |
| Face Value | โน10 Per Equity Share |
| Price Band | โน133.00-140.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | ACCENTMIC |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Corporate Capital Ventures Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,000 shares and in multiples thereof
Accent Microcell Limited, founded in 2012, manufactures cellulose-based excipients for pharmaceutical, nutritional supplements, food, cosmetics, and other industries.
The company manufactures over 22 grades of MCC with particle sizes ranging from 20 to 180 microns, marketed under the brand names: Accel, Acrocell, Maccel, and Vincel.
The products can be divided into two categories: Spray-dried products and Spin-flash-dried products. The company's product portfolio includes:
Under the Accel/Vincel brand names: Microcrystalline Cellulose (MCC) - Spray Dried/ Spin Flash Dried, Microcrystalline Cellulose Spheres (MCC Spheres), Silicified Microcrystalline Cellulose (SMCC), Powdered Cellulose (PC), Microcrystalline Cellulose with Carboxy Methyl Cellulose (Co-Processed)
Accent Microcell has two manufacturing facilities at Pirana Road, Ahmedabad, and Dahej, SEZ (Bharuch) with a capacity of 8,000 metric tonnes. The Pirana facility (Unit I) is geared towards manufacturing MCC, SMCC, PC, and MCC with CMC, while the Dahej, SEZ facility (Unit II) is geared towards manufacturing MCC, MCC sphere, SMCC, and MCC with CMC for export to overseas customers.
The company's customers come from 45 different countries, including the US, Canada, Germany, the UK, Japan, China, Australia, Korea, the Netherlands, Turkey, Vietnam, Italy, Indonesia, Poland, Egypt, France, Thailand, New Zealand, Brazil, Russia, Mexico, Chile, Zimbabwe, Denmark, Greece and many others.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | To Set up plant at Navagam Kheda for manufacturing Croscarmellose Sodium (โCCSโ), Sodium Starch Glycolate and Carboxymethylcellulose (CMC); and | 54.39 |
| 2 | General Corporate Expenses | 17.90 |
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 122.15 | 114.10 | 94.61 | 80.70 |
| Total Income | 59.93 | 206.97 | 167.54 | 134.82 |
| Profit After Tax | 7.06 | 13.01 | 5.89 | 4.80 |
| NET Worth | 51.25 | 44.20 | 32.09 | 26.63 |
| Reserves and Surplus | 38.31 | 31.26 | 19.19 | 22.33 |
| Total Borrowing | 21.06 | 22.78 | 24.10 | 30.64 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 34.11% |
| ROCE | 26.46% |
| Debt / Equity | 0.52% |
| RoNW | 29.44% |
| PAT Margin | 6.37% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 10.06 | |
| P/E (x) | 13.92 | 10.44 |
| Promoter Holding | 73.13% | 53.67% |
| Market Cap | โน294.60 Cr. | |